Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080680234> ?p ?o ?g. }
- W3080680234 endingPage "e0237787" @default.
- W3080680234 startingPage "e0237787" @default.
- W3080680234 abstract "Introduction Afghanistan is affected by one of the world’s longest protracted armed conflicts, frequent natural disasters, disease outbreaks and large population movements and it suffers from a high burden of tuberculosis (TB), including rifampicin-resistant TB (RR-TB). The study shows Médecins Sans Frontières’ experiences with care for patients with RR-TB in Kandahar Province. We describe the uptake of RR-TB treatment, how World Health Organisation criteria for the choice between the short and an individualized regimen were implemented, and treatment outcomes. Methods This is a retrospective cohort analysis of routinely collected data from RR-TB patients enrolled in care from 2016 until 2019. Descriptive analysis was performed to present characteristics of patients and treatment outcomes. Multivariable Cox analysis was performed to identify risk factors for having an unfavourable treatment outcome. Results Out of 146 enrolled RR-TB patients, 112 (76.7%) started treatment: 41 (36.6%) and 71 (63.4%) with the short and individualized treatment regimen, respectively. Of 82 with results for fluoroquinolone susceptibility, 39 (47.6%) had fluoroquinolone-resistant TB. Seven patients with initially fluoroquinolone-resistant TB and three pregnant women started the short regimen and 18 patients eligible for the short regimen started the injectable-free individualized regimen. Overall, six-month smear and culture conversion were 98.7% and 97.1%, respectively; treatment success was 70.1%. Known initial fluoroquinolone resistance (aHR 3.77, 95%CI:1.53–9.27) but not choice of regimen predicted having an unfavourable outcome. Conclusion Even though criteria for the choice of treatment regimen were not applied strictly, we have achieved acceptable outcomes in this cohort. To expand RR-TB care, treatment regimens should fit provision at primary health care level and take patient preferences into account." @default.
- W3080680234 created "2020-09-01" @default.
- W3080680234 creator A5003791115 @default.
- W3080680234 creator A5009211949 @default.
- W3080680234 creator A5010344676 @default.
- W3080680234 creator A5014839628 @default.
- W3080680234 creator A5021161270 @default.
- W3080680234 creator A5028128458 @default.
- W3080680234 creator A5029102298 @default.
- W3080680234 creator A5030071152 @default.
- W3080680234 creator A5041544534 @default.
- W3080680234 creator A5046334059 @default.
- W3080680234 creator A5059489482 @default.
- W3080680234 creator A5068795541 @default.
- W3080680234 creator A5076194983 @default.
- W3080680234 creator A5084823310 @default.
- W3080680234 creator A5090351129 @default.
- W3080680234 date "2020-08-21" @default.
- W3080680234 modified "2023-10-01" @default.
- W3080680234 title "Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study" @default.
- W3080680234 cites W1453184674 @default.
- W3080680234 cites W2032357055 @default.
- W3080680234 cites W2036580419 @default.
- W3080680234 cites W2064058371 @default.
- W3080680234 cites W2065656542 @default.
- W3080680234 cites W2066697875 @default.
- W3080680234 cites W2126637272 @default.
- W3080680234 cites W2147353037 @default.
- W3080680234 cites W2150736904 @default.
- W3080680234 cites W2154336124 @default.
- W3080680234 cites W2157229990 @default.
- W3080680234 cites W2324926034 @default.
- W3080680234 cites W2417325503 @default.
- W3080680234 cites W2512841049 @default.
- W3080680234 cites W2553397486 @default.
- W3080680234 cites W2561712576 @default.
- W3080680234 cites W2598478177 @default.
- W3080680234 cites W2601437729 @default.
- W3080680234 cites W2618241403 @default.
- W3080680234 cites W2741120696 @default.
- W3080680234 cites W2802350967 @default.
- W3080680234 cites W2808663005 @default.
- W3080680234 cites W2895464336 @default.
- W3080680234 cites W2905003824 @default.
- W3080680234 cites W2927330151 @default.
- W3080680234 cites W2942940267 @default.
- W3080680234 cites W2962749505 @default.
- W3080680234 cites W2978616820 @default.
- W3080680234 cites W2985711850 @default.
- W3080680234 cites W2990049584 @default.
- W3080680234 cites W2995747718 @default.
- W3080680234 cites W4256453196 @default.
- W3080680234 doi "https://doi.org/10.1371/journal.pone.0237787" @default.
- W3080680234 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7446914" @default.
- W3080680234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32822375" @default.
- W3080680234 hasPublicationYear "2020" @default.
- W3080680234 type Work @default.
- W3080680234 sameAs 3080680234 @default.
- W3080680234 citedByCount "6" @default.
- W3080680234 countsByYear W30806802342022 @default.
- W3080680234 countsByYear W30806802342023 @default.
- W3080680234 crossrefType "journal-article" @default.
- W3080680234 hasAuthorship W3080680234A5003791115 @default.
- W3080680234 hasAuthorship W3080680234A5009211949 @default.
- W3080680234 hasAuthorship W3080680234A5010344676 @default.
- W3080680234 hasAuthorship W3080680234A5014839628 @default.
- W3080680234 hasAuthorship W3080680234A5021161270 @default.
- W3080680234 hasAuthorship W3080680234A5028128458 @default.
- W3080680234 hasAuthorship W3080680234A5029102298 @default.
- W3080680234 hasAuthorship W3080680234A5030071152 @default.
- W3080680234 hasAuthorship W3080680234A5041544534 @default.
- W3080680234 hasAuthorship W3080680234A5046334059 @default.
- W3080680234 hasAuthorship W3080680234A5059489482 @default.
- W3080680234 hasAuthorship W3080680234A5068795541 @default.
- W3080680234 hasAuthorship W3080680234A5076194983 @default.
- W3080680234 hasAuthorship W3080680234A5084823310 @default.
- W3080680234 hasAuthorship W3080680234A5090351129 @default.
- W3080680234 hasBestOaLocation W30806802341 @default.
- W3080680234 hasConcept C126322002 @default.
- W3080680234 hasConcept C142724271 @default.
- W3080680234 hasConcept C167135981 @default.
- W3080680234 hasConcept C187212893 @default.
- W3080680234 hasConcept C201903717 @default.
- W3080680234 hasConcept C2776301714 @default.
- W3080680234 hasConcept C2777025531 @default.
- W3080680234 hasConcept C2777107064 @default.
- W3080680234 hasConcept C2777768864 @default.
- W3080680234 hasConcept C2777975735 @default.
- W3080680234 hasConcept C2781069245 @default.
- W3080680234 hasConcept C2781413609 @default.
- W3080680234 hasConcept C2908647359 @default.
- W3080680234 hasConcept C71924100 @default.
- W3080680234 hasConcept C72563966 @default.
- W3080680234 hasConcept C99454951 @default.
- W3080680234 hasConceptScore W3080680234C126322002 @default.
- W3080680234 hasConceptScore W3080680234C142724271 @default.
- W3080680234 hasConceptScore W3080680234C167135981 @default.
- W3080680234 hasConceptScore W3080680234C187212893 @default.